The Global Asthma
Market research report interprets
definition, an investigation of significant progress in the industry. It
provides overall industry survey, product description, wide array of
applications, top players, and development forecast. It enhances understanding
about that market along with new business trends.
Asthma is a lung disease;
i.e. a chronic condition that causes inflammation and narrowing of the
bronchial tube (the passageways that permit air to pass in and leave the
lungs). Some of the symptoms of asthma include shortness of breath, coughing,
wheezing and chest tightness. The factors that propel the Asthma Market size
include innovation in drugs, rising occurrences of asthma cases, mounting
geriatric population, rising number of smokers, growth in the disposable
income, developing healthcare infrastructure and facilities, and intensifying
pollution level.
Download Free Sample
Report Now @ https://www.millioninsights.com/industry-reports/asthma-market/request-sample
Main features of the report:
·
To provide
detailed analysis of the market structure along with forecast of the various
segments and sub-segments of the global Asthma Market.
·
A complete
backdrop analysis, which includes an assessment of the parent market
·
Important
changes in market dynamics
·
Market
segmentation up to the second or third level
·
To provide
country level analysis of the market for segment by application, product type
and sub-segments.
·
To provide
strategic profiling of key players in the market, comprehensively analyzing
their core competencies, and drawing a competitive landscape for the market.
·
Track and
analyze competitive developments such as joint ventures, strategic alliances,
mergers and acquisitions, new product developments, and research and
developments in the global Asthma Market.
·
Emerging
niche segments and regional markets
·
An
objective assessment of the trajectory of the industry.
On the other hand, there
are also factors that hinder the global Asthma Market size such as the patent expiry
of drugs, high expenditure on treatment, and growth in use of generic drugs.
The global Asthma Market size spans type, device type, drug type, route of
administration, and geography. On the basis of type, the global Asthma Market
size constitutes allergic asthma and non-allergic asthma. The allergic asthma
is basically caused due to exposure to allergens like pollens from weeds,
trees, etc., dust, and so on. On the other hand, the non-allergic asthma is
basically caused due to exercise, stress, cold, flu, etc.
On the basis of device
type, the global Asthma Market size constitutes inhalers and nebulizers. The
“inhalers” segment is further sub-categorized as dry powder, soft mist inhalers
(SMIs), metered dose inhalers (MDIs). Nebulizers are devices that carry the
drug in a fluid form that is dispensed by the compressed air. The “nebulizers”
segment is further sub-categorized as mesh nebulizers, compressor nebulizers,
and ultrasonic nebulizers. In 2015, the metered dose inhalers (MDIs) accounted
for the largest share of the global Asthma Market owing to the ease of
availability, consistency, portability, flexibility, and cost-effectiveness.
The features like
portability, noteworthy benefits in the home healthcare applications, and ideal
design that enables dispense medication directly to the respiratory track are
estimated to offer prospective growth opportunities for its high utility. On the basis of drug type, the global Asthma
Market size spans anti-inflammatory, immunosuppressant, bronchodilators, mast
cell stabilizers, leukotriene antagonists, and combination of ICS/LABA. In this
segmentation, the combination drug type consisting of inhaled corticosteroids
with long-acting beta agonists dominated the global Asthma Market in 2015. The
factors that attribute to the large share of combination drug type are rise in
application rates due to twofold action of combination therapy and its high
efficacy rate.
On the basis of route of
administration, the global Asthma Market size spans inhaled, oral, intravenous,
and subcutaneous. The inhaled route of administration accounted for the largest
market share of the Asthma Market in 2015.
On the basis of geography, the global Asthma Market size constitutes
North America, Europe, Asia Pacific, and Rest of the World. North America holds
the largest share of the global Asthma Market due to rising number of asthma
patients, increase in geriatric population, drug innovation, high-tech
advancement, and developed healthcare infrastructure. The North American market
is tracked by Europe. During the forecast period, the Asia Pacific’s market is
projected to witness a high growth rate owing to factors such as rise in
population, increasing number of asthma patients, emerging healthcare
infrastructure and facilities, environmental pollution, growing disposable
income, and enlarging number of smokers.
Some of the prominent
players that fuel the growth of the Asthma Market include AstraZeneca Plc,
Philips Healthcare, 3M Health Care, Allied Healthcare Products Inc., Sunovion
Pharmaceuticals Inc., GlaxoSmithKline Plc, Novartis AG, Merck & Co., Inc.,
GF Healthcare Products, Smith Medicals, Lincare Holdings Inc., and Baxter
International.
Know
More Insights @ https://newsonmarketblog.wordpress.com
No comments:
Post a Comment